Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.446NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.76 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.398NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.163NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22077.4South Korea
P.3 (Theta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAVNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.77NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.99NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBF.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.343NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.4.17 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.25.1.2 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.409NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.83NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.310NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.362.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.162NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Y.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.86NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.154NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.4.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
A.2.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.41NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.137NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.446NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.76 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.398NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.163NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
P.3 (Theta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.38.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XAVNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BE.1.4.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBC.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BM.4.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.20NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.77NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CP.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FC.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BY.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.7.17NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.123 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BQ.1.27NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BQ.1.1.71NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.12.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
DN.1.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used